Identification of immune responses against neuronal proteins in patients with cancer and neurologic disorders (paraneoplastic neurologic disorders [PNDs]) has uncovered the existence of antigens (onconeuronal proteins) shared by some cancers and the nervous system. These onconeuronal proteins are targets of humoral and cell mediated immune responses, which result in degeneration of discrete or multifocal areas of the nervous system, producing severe neurologic deficits and often death. Tumors that elicit PND appear to be more indolent than tumors from patients without PND and usually remain elusive to clinical detection. In 1999, we reported on two related proteins (Mal and Ma2) that are targets of immunity associated with certain cancers and PND. Since then, we have identified 16 new patients with immunity to Ma proteins and isolated another protein member (Ma3). We believe that the Ma proteins comprise a large family of onconeuronal antigens targeted by immune responses associated with PND. We hypothesize that the expression of Ma proteins by the tumor is able to break immune tolerance for these proteins, resulting in the production of autoreactive immune B and T-cells against the tumor and the nervous system; that the type of PND depends on which Ma proteins are recognized by the immune response; and that T-cell mechanisms are involved.
In Aim 1, we will identify additional Ma family members and determine the identity and sequence of the Ma proteins expressed by normal tissues and tumors.
In Aim 2, we will identify the immunodominant regions of the Ma proteins and determine the extent of disease protein specificity.
In Aim 3, we will isolate the mouse Ma sequences and develop a model of anti-tumor immunity and neuronal injury using Ma cDNA and protein vaccination. Our methods will include immunohistochemical and other antibody-related studies, standard molecular biology techniques, and small animal surgery. These studies will provide insights into the role of Ma proteins in the development of PND and will generate immunodominant protein fragments to be used for diagnosis of PND, with prognostic and possibly therapeutic implications. The development of an animal model of PND will help to understand these disorders and is an absolute requirement for developing therapeutic strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA089054-04
Application #
6691749
Study Section
Special Emphasis Panel (ZRG1-BDCN-4 (01))
Program Officer
Mccarthy, Susan A
Project Start
2001-07-01
Project End
2005-06-30
Budget Start
2003-07-01
Budget End
2004-06-30
Support Year
4
Fiscal Year
2003
Total Cost
$263,110
Indirect Cost
Name
University of Pennsylvania
Department
Neurology
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Höftberger, Romana; Sepulveda, María; Armangue, Thaís et al. (2015) Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the disease. Mult Scler 21:866-874
Armangue, Thaís; Titulaer, Maarten J; Sabater, Lidia et al. (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75:435-41
Kruer, Michael C; Hoeftberger, Romana; Lim, Kit Yeng et al. (2014) Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures: the first pediatric case of ?-aminobutyric acid type B receptor autoimmunity. JAMA Neurol 71:620-3
Höftberger, Romana; Sabater, Lidia; Velasco, Fernando et al. (2014) Carbonic anhydrase-related protein VIII antibodies and paraneoplastic cerebellar degeneration. Neuropathol Appl Neurobiol 40:650-3
Höftberger, Romana; Titulaer, Maarten J; Sabater, Lidia et al. (2013) Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 81:1500-6
Titulaer, Maarten J; McCracken, Lindsey; Gabilondo, Iñigo et al. (2013) Late-onset anti-NMDA receptor encephalitis. Neurology 81:1058-63
Labate, Angelo; Quattrone, Aldo; Dalmau, Josep et al. (2013) Anti-N-methyl-D-aspartate-glutamic-receptor encephalitis presenting as paroxysmal exercise-induced foot weakness. Mov Disord 28:820-2
Höftberger, Romana; Sabater, Lidia; Ortega, Angel et al. (2013) Patient with homer-3 antibodies and cerebellitis. JAMA Neurol 70:506-9
Titulaer, Maarten J; McCracken, Lindsey; Gabilondo, Iñigo et al. (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157-65
Armangue, Thaís; Titulaer, Maarten J; Málaga, Ignacio et al. (2013) Pediatric anti-N-methyl-D-aspartate receptor encephalitis-clinical analysis and novel findings in a series of 20 patients. J Pediatr 162:850-856.e2

Showing the most recent 10 out of 91 publications